|By Marketwired .||
|May 29, 2014 09:01 AM EDT||
NEWPORT BEACH, CA -- (Marketwired) -- 05/29/14 -- Dr. Nancy L. Silverberg, a dermatologist in Newport Beach, has added JUVÉDERM VOLUMA XC -- the first and only U.S. Food and Drug Administration-approved, hyaluronic acid-based filler for cheek-related volume loss -- to her practice's selection of cosmetic dermatology treatments. For patients seeking to nonsurgically restore fullness to the face and achieve a more youthful-looking appearance, JUVÉDERM VOLUMA XC may present an ideal solution, says Dr. Silverberg.
"The most common product we used for volume replacement before VOLUMA was Sculptra®," she says. "Sculptra® is still used for this indication, although it works differently. Sculptra® stimulates the body's own collagen over time (about six months) whereas VOLUMA is an immediate filler."
In a recent blog post titled, "Benefits of JUVÉDERM VOLUMA XC," Dr. Silverberg also explains that although JUVÉDERM VOLUMA XC is a hyaluronic acid (HA) filler, the product is a thicker injectable gel, and as result, degrades more slowly, offering patients the unique advantage of longevity. Whereas most HA fillers last several months, JUVÉDERM VOLUMA XC is clinically proven to last up to two years, explains Dr. Silverberg.
While many nonsurgical facial rejuvenation products are currently available to smooth fine lines and wrinkles, JUVÉDERM VOLUMA XC is distinct because it presents a new kind of solution to the second component of facial aging: volume deficiency. "Products such as Perlane® and Restylane®, like Juvederm® XC, are used for wrinkle correction," says Dr. Silverberg. JUVÉDERM VOLUMA XC was created for larger-scale volume replacement and specifically to add fullness to all three areas of the cheek: apex, apple, and hollow. It is also made with Lidocaine, a local anesthetic, to help minimize discomfort during the injection, she says.
Ultimately, Dr. Silverberg says patients who are looking to achieve a more youthful, natural appearance through nonsurgical facial rejuvenation should speak to their dermatologist or medical care professional. Each injectable treatment can offer select benefits in addressing age-related concerns, she says, adding that it is important for patients to discuss their goals and aesthetic concerns with a board-certified physician so they can more effectively achieve the balanced, natural-looking results they desire.
About Nancy L. Silverberg, MD
Dr. Silverberg is a graduate of Cornell University and went on to earn her medical degree from St. Louis University School of Medicine. She is a certified by the American Board of Dermatology and has served the medical and cosmetic dermatology needs of Newport Beach community for 29 years. Dr. Silverberg is an Associate Clinical Professor of Dermatology at University California Irvine, and she previously served as Chairman of Dermatology for Hoag Hospital Newport Beach. She holds memberships in many prestigious medical organizations, such as the American Society for Dermatologic Surgery and International Society of Dermatology. Dr. Silverberg is a Fellow of the American Academy of Dermatology, a Fellow of the American Society for Mohs Surgery, and a Diplomate of the American Board of Dermatology. She is available for interview upon request.
To learn more about Silverberg Surgical & Medical Group, please visit silverbergmd.com and facebook.com/silverbergmd.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2603896
Back in February of 2017, Andrew Clay Schafer of Pivotal tweeted the following: “seriously tho, the whole software industry is stuck on deployment when we desperately need architecture and telemetry.” Intrigue in a 140 characters. For me, I hear Andrew saying, “we’re jumping to step 5 before we’ve successfully completed steps 1-4.”
Apr. 24, 2017 07:30 AM EDT Reads: 1,396
Apr. 24, 2017 07:15 AM EDT Reads: 1,931
Apr. 24, 2017 07:15 AM EDT
Apr. 24, 2017 07:00 AM EDT Reads: 102
Apr. 24, 2017 06:45 AM EDT Reads: 16,063
Apr. 24, 2017 06:15 AM EDT Reads: 2,837
Apr. 24, 2017 06:00 AM EDT Reads: 150
Apr. 24, 2017 05:15 AM EDT Reads: 203
Apr. 24, 2017 05:00 AM EDT Reads: 1,710
Apr. 24, 2017 04:45 AM EDT Reads: 230
Apr. 24, 2017 04:15 AM EDT Reads: 225
Apr. 24, 2017 04:15 AM EDT Reads: 1,830
Apr. 24, 2017 04:00 AM EDT Reads: 4,833
Apr. 24, 2017 02:45 AM EDT Reads: 842
Apr. 24, 2017 02:45 AM EDT Reads: 886